Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,696 public trials 1,038 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

A Randomized Trial Of PF-00299804 Taken Orally Versus Erlotinib Taken Orally For Treatment Of Advanced Non-Small Cell Lung Cancer That Has Progressed After One Or Two Prior Chemotherapy Regimen

NCT00769067

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Northwest Alabama Cancer Center Muscle Shoals, Alabama, United States
  • Agajanian Institute of Oncology and Hematology Montebello, California, United States
  • Bridgeport Hospital Bridgeport, Connecticut, United States
  • Wittingham Cancer Center @ Norwalk Hospital Norwalk, Connecticut, United States
View all 59 locations
View Trial Details
Completed

Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 (Afatinib) Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EGFR Mutation and/or Disease Progression Following Prior Erlotinib or Gefitinib

NCT00993499

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • 1200.70.34001 Boehringer Ingelheim Investigational Site Badalona (Barcelona), Spain
  • 1200.70.34008 Boehringer Ingelheim Investigational Site Barcelona, Spain
  • 1200.70.34009 Boehringer Ingelheim Investigational Site Barcelona, Spain
  • 1200.70.34006 Boehringer Ingelheim Investigational Site Girona, Spain
View Trial Details
Completed

Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer

NCT01090011

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • 1200.71.1004 Boehringer Ingelheim Investigational Site Aurora, Colorado, United States
  • 1200.71.1003 Boehringer Ingelheim Investigational Site New Haven, Connecticut, United States
  • 1200.71.1001 Boehringer Ingelheim Investigational Site New York, United States
  • 1200.71.1002 Boehringer Ingelheim Investigational Site Nashville, Tennessee, United States
View Trial Details
Completed

Cabazitaxel in Relapsed and Metastatic NSCLC

NCT01852578

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • "Ag. Georgios" General Hospital of Chania Chania, Crete, Greece
  • University Hospital of Crete, Dep of Medical Oncology Heraklion, Greece Heraklion, Crete, Greece
  • "IASO" General Hospital of Athens Athens, Greece Athens, Greece
  • Air Forces Military Hospital of Athens Athens, Greece Athens, Greece
View Trial Details
Completed

Bortezomib in Combination With Gemcitabine and Cisplatin in Advanced or Metastatic Non-Small Cell Lung Cancer

NCT01633645

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • Air Forces Military Hospital of Athens Athens, Greece Athens, Greece
  • METAXA Hospital, B' Pathology Department Athens, Greece
  • SOTIRIA Hospital, Medical Oncology Department Athens, Greece
  • University Hospital of Crete, Dep of Medical Oncology Heraklion, Greece Heraklion, Greece
View Trial Details
Completed

DNA Chip Based Prognosis of Lung Cancer

NCT00973427

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Aarhus University Hospital Aarhus, Denmark
  • University of Copenhagen Copenhagen, Denmark
View Trial Details

Related conditions